Literature DB >> 14736538

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

Marc van Bilsen1, Pascal J H Smeets, Andries J Gilde, Ger J van der Vusse.   

Abstract

It has been postulated that the failing heart suffers from chronic energy starvation, and that derangements in cardiac energy conversion are accessory to the progressive nature of this disease. The molecular mechanisms driving this 'metabolic remodelling' process and their significance for the development of cardiac failure are still open to discussion. Next to changes in mitochondrial function, the hypertrophied heart is characterized by a marked shift in substrate preference away from fatty acids towards glucose. It has been argued that the decline in fatty acid oxidation is not fully compensated for by a rise in glucose oxidation, thereby imposing an additional burden on overall ATP generating capacity. Several lines of evidence suggest that these metabolic adaptations are brought about, at least in part, by alterations in the rate of transcription of genes encoding for proteins involved in substrate transport and metabolism. Here, the principal metabolic changes are reviewed and the various molecular mechanisms that are likely to play a role are discussed. In addition, the potential significance of these changes for the aetiology of heart failure is evaluated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736538     DOI: 10.1016/j.cardiores.2003.11.014

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  79 in total

Review 1.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

Review 2.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

Review 3.  Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes.

Authors:  Jennifer G Duncan
Journal:  Pediatr Cardiol       Date:  2011-02-02       Impact factor: 1.655

Review 4.  Telomeres and mitochondria in the aging heart.

Authors:  Javid Moslehi; Ronald A DePinho; Ergün Sahin
Journal:  Circ Res       Date:  2012-04-27       Impact factor: 17.367

Review 5.  Mitochondrial centrality in heart failure.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2008-01-05       Impact factor: 4.214

6.  Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.

Authors:  Haipeng Sun; Kristine C Olson; Chen Gao; Domenick A Prosdocimo; Meiyi Zhou; Zhihua Wang; Darwin Jeyaraj; Ji-Youn Youn; Shuxun Ren; Yunxia Liu; Christoph D Rau; Svati Shah; Olga Ilkayeva; Wen-Jun Gui; Noelle S William; R Max Wynn; Christopher B Newgard; Hua Cai; Xinshu Xiao; David T Chuang; Paul Christian Schulze; Christopher Lynch; Mukesh K Jain; Yibin Wang
Journal:  Circulation       Date:  2016-04-08       Impact factor: 29.690

7.  Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Delaine K Ceholski; Irene C Turnbull; Chi-Wing Kong; Simon Koplev; Joshua Mayourian; Przemek A Gorski; Francesca Stillitano; Angelos A Skodras; Mathieu Nonnenmacher; Ninette Cohen; Johan L M Björkegren; Daniel R Stroik; Razvan L Cornea; David D Thomas; Ronald A Li; Kevin D Costa; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2018-05-09       Impact factor: 5.000

Review 8.  Cardiac metaiodobenzylguanidine imaging and heart failure.

Authors:  Tomoaki Nakata; Akiyoshi Hashimoto; Hirohito Sugawara
Journal:  Curr Heart Fail Rep       Date:  2013-12

9.  Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.

Authors:  J Michael O'Donnell; Aaron Fields; Xianyao Xu; Shamim A K Chowdhury; David L Geenen; Jian Bi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

10.  The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover.

Authors:  J Michael O'Donnell; Aaron D Fields; Natalia Sorokina; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2007-11-24       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.